• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2,5-二取代-1,3,4-恶二唑类似物酪氨酸酶抑制组合库的构效关系

Structure-activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues.

作者信息

Khan Mahmud Tareq Hassan, Choudhary Muhammad Iqbal, Khan Khalid Mohammed, Rani Mubeen

机构信息

Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh.

出版信息

Bioorg Med Chem. 2005 May 16;13(10):3385-95. doi: 10.1016/j.bmc.2005.03.012.

DOI:10.1016/j.bmc.2005.03.012
PMID:15934142
Abstract

Here the tyrosinase inhibition studies of library of 2,5-disubstituted-1,3,4-oxadiazoles have been reported and their structure-activity relationship (SAR) also have been discussed. The library of the oxadiazoles was synthesized under the microwave irradiation and was structures of these were characterized by different spectral techniques. From this study it could be concluded that for a better inhibition of tyrosinase, electronegative substitution is essential as most probably the active site of the enzyme contain some hydrophobic site and position is also very important for the inhibition purposes due to the conformational space. The electronegativity of the compounds is somewhat proportional to the inhibitory activity. The compound 3e (3'-[5-(4'-bromophenyl)-1,3,4-oxadiazol-2-yl]pyridine) exhibited most potent (IC50 = 2.18 microM) inhibition against the enzyme tyrosinase which is more potent than the standard potent inhibitor L-mimosine (IC50 = 3.68 microM). This molecule can be the best candidate as a lead compound for further development of drug for the treatments of several skin disorders.

摘要

本文报道了2,5-二取代-1,3,4-恶二唑库的酪氨酸酶抑制研究,并讨论了其构效关系(SAR)。恶二唑库在微波辐射下合成,其结构通过不同的光谱技术进行表征。从这项研究可以得出结论,为了更好地抑制酪氨酸酶,电负性取代是必不可少的,因为酶的活性位点很可能包含一些疏水位点,并且由于构象空间的原因,位置对于抑制目的也非常重要。化合物的电负性与抑制活性在一定程度上成正比。化合物3e(3'-[5-(4'-溴苯基)-1,3,4-恶二唑-2-基]吡啶)对酪氨酸酶表现出最有效的抑制作用(IC50 = 2.18 microM),比标准强效抑制剂L-含羞草碱(IC50 = 3.68 microM)更有效。该分子可作为先导化合物,用于进一步开发治疗多种皮肤疾病的药物。

相似文献

1
Structure-activity relationships of tyrosinase inhibitory combinatorial library of 2,5-disubstituted-1,3,4-oxadiazole analogues.2,5-二取代-1,3,4-恶二唑类似物酪氨酸酶抑制组合库的构效关系
Bioorg Med Chem. 2005 May 16;13(10):3385-95. doi: 10.1016/j.bmc.2005.03.012.
2
Novel 1,3,4-oxadiazole compounds inhibit the tyrosinase and melanin level: Synthesis, in-vitro, and in-silico studies.新型 1,3,4-噁二唑类化合物对酪氨酸酶和黑色素水平的抑制作用:合成、体外及计算机模拟研究。
Bioorg Med Chem. 2021 Jul 1;41:116222. doi: 10.1016/j.bmc.2021.116222. Epub 2021 May 21.
3
Mushroom tyrosinase inhibition by two potent uncompetitive inhibitors.两种强效非竞争性抑制剂对蘑菇酪氨酸酶的抑制作用
J Enzyme Inhib Med Chem. 2004 Aug;19(4):349-53. doi: 10.1080/14756360409162449.
4
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors.(1H-咪唑并[4,5-c]吡啶-2-基)-1,2,5-恶二唑-3-基胺衍生物:作为高效且选择性的MSK-1抑制剂的进一步优化
Bioorg Med Chem Lett. 2005 Jul 15;15(14):3407-11. doi: 10.1016/j.bmcl.2005.05.020.
5
Synthesis and biological activity of oxadiazole and triazolothiadiazole derivatives as tyrosinase inhibitors.恶二唑和三唑并噻二唑衍生物的合成及作为酪氨酸酶抑制剂的生物活性。
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3755-9. doi: 10.1016/j.bmcl.2010.04.067. Epub 2010 Apr 18.
6
Design and synthesis of novel hydroxypyridinone derivatives as potential tyrosinase inhibitors.新型羟基吡啶酮衍生物作为潜在酪氨酸酶抑制剂的设计与合成
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3103-3108. doi: 10.1016/j.bmcl.2016.05.006. Epub 2016 May 4.
7
Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.新型伞形酮类似物作为潜在蘑菇酪氨酸酶抑制剂的设计、合成及生物活性评价
J Enzyme Inhib Med Chem. 2015 Dec;30(6):874-83. doi: 10.3109/14756366.2014.979346. Epub 2015 Feb 3.
8
Potent tyrosinase inhibitors from Trifolium balansae.来自巴氏车轴草的强效酪氨酸酶抑制剂。
Nat Prod Res. 2006 Jun;20(7):665-70. doi: 10.1080/14786410500196821.
9
Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.恶二唑衍生物的合成、分子对接研究及体外胸苷磷酸化酶抑制活性。
Bioorg Chem. 2018 Aug;78:58-67. doi: 10.1016/j.bioorg.2018.02.020. Epub 2018 Mar 7.
10
Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase.新型基于羟基苯甲醛的曲酸类似物作为蘑菇酪氨酸酶抑制剂的合成及生物学评价
Bioorg Med Chem Lett. 2017 Feb 1;27(3):530-532. doi: 10.1016/j.bmcl.2016.12.027. Epub 2016 Dec 9.

引用本文的文献

1
Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases.具有抗氧化活性的苯亚甲基-3-甲基-2-硫代噻唑烷-4-酮类似物抑制蘑菇和哺乳动物酪氨酸酶的功效研究。
Molecules. 2024 Jun 18;29(12):2887. doi: 10.3390/molecules29122887.
2
Tyrosinase Inhibitors: A Perspective.酪氨酸酶抑制剂:一个视角。
Molecules. 2023 Jul 30;28(15):5762. doi: 10.3390/molecules28155762.
3
An Understanding of Mechanism-Based Approaches for 1,3,4-Oxadiazole Scaffolds as Cytotoxic Agents and Enzyme Inhibitors.
对基于机制的1,3,4-恶二唑支架作为细胞毒性剂和酶抑制剂的方法的理解。
Pharmaceuticals (Basel). 2023 Feb 7;16(2):254. doi: 10.3390/ph16020254.
4
Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives.新型4-(取代苯基-1,3,4-恶二唑/噻二唑-2-基)-4-(4-取代苯基)氮杂环丁烷-2-酮衍生物的合成、抗癌、抗菌和抗氧化潜力
Pharmaceuticals (Basel). 2023 Mar 30;16(4):517. doi: 10.3390/ph16040517.
5
Synthesis of new oxadiazol-phthalazinone derivatives with anti-proliferative activity; molecular docking, pro-apoptotic, and enzyme inhibition profile.具有抗增殖活性的新型恶二唑并酞嗪酮衍生物的合成;分子对接、促凋亡及酶抑制谱
RSC Adv. 2020 Jan 22;10(7):3675-3688. doi: 10.1039/c9ra09016a.
6
Crystal structure and Hirshfeld surface analysis of 1-(4-chloro-phen-yl)-2-{[5-(4-chloro-phen-yl)-1,3,4-oxa-diazol-2-yl]sulfan-yl}ethanone.1-(4-氯苯基)-2-{[5-(4-氯苯基)-1,3,4-恶二唑-2-基]硫基}乙酮的晶体结构与 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2017 Mar 17;73(Pt 4):524-527. doi: 10.1107/S2056989017003978. eCollection 2017 Apr 1.
7
Synthetic approaches and pharmacological activity of 1,3,4-oxadiazoles: a review of the literature from 2000-2012.1,3,4-噁二唑类化合物的合成方法及药理活性:2000-2012 年文献综述。
Molecules. 2012 Aug 27;17(9):10192-231. doi: 10.3390/molecules170910192.
8
(S)-N-{1-[5-(4-Chloro-benzyl-sulfanyl)-1,3,4-oxadiazol-2-yl]eth-yl}-4-methyl-benzene-sulfonamide.(S)-N-{1-[5-(4-氯苄基硫烷基)-1,3,4-恶二唑-2-基]乙基}-4-甲基苯磺酰胺
Acta Crystallogr Sect E Struct Rep Online. 2011 Oct 1;67(Pt 10):o2793. doi: 10.1107/S1600536811039134. Epub 2011 Sep 30.
9
5-[1-(3,4-Dichloro-phen-oxy)eth-yl]-1,3,4-oxadiazole-2(3H)-thione hemihydrate.5-[1-(3,4-二氯苯氧基)乙基]-1,3,4-恶二唑-2(3H)-硫酮半水合物
Acta Crystallogr Sect E Struct Rep Online. 2009 Aug 8;65(Pt 9):o2075-6. doi: 10.1107/S1600536809029894.
10
An updated review of tyrosinase inhibitors.酪氨酸酶抑制剂的最新综述。
Int J Mol Sci. 2009 May 26;10(6):2440-2475. doi: 10.3390/ijms10062440.